MCTA News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

Loading chart

Pay with

MC

Mkt Cap

N/A

Volume

N/A

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmThe Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 after its shares spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors are encouraged to contact the firm before February 17, 2026.Benzinga · Feb 17, 2026

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmThe Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21-November 12, 2025, for a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 following allegations of a promotion scheme involving social media advisors touting the stock without legitimate news justification. Investors are encouraged to join the case to recover losses.GlobeNewswire Inc. · Feb 16, 2026

Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff DeadlineA class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) for allegedly failing to disclose a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. The stock surged from $4.00 to $29.36 between October 10 and November 12, 2025, before the SEC halted trading. Investors who purchased shares during this period have until February 17, 2026, to apply as lead plaintiffs.GlobeNewswire Inc. · Feb 15, 2026

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmThe Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 following a dramatic stock price spike attributed to a promotion scheme involving social media advisors, with no legitimate company news justifying the increase.Benzinga · Feb 13, 2026

Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTAThe DJS Law Group has filed a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for securities law violations. The SEC suspended trading of the company's shares following an investigation into an alleged scheme where financial advisors touted shares on social media to artificially boost the stock price. The lawsuit covers the period from October 21, 2025 to November 12, 2025, with a deadline of February 17, 2026 for shareholders to join.Benzinga · Feb 13, 2026

Deadline Approaching: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. SmithThe Law Offices of Howard G. Smith reminds investors of the February 17, 2026 deadline to file a lead plaintiff motion in a securities fraud class action lawsuit against Charming Medical Limited (NASDAQ: MCTA). The SEC halted trading of MCTA on November 11, 2025 due to potential market manipulation involving social media-based fraudulent stock promotion schemes. The complaint alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity that inflated the stock price.Benzinga · Feb 12, 2026

Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitThe Law Offices of Frank R. Cruz reminds investors of the February 17, 2026 deadline to participate as lead plaintiff in a securities fraud class action lawsuit against Charming Medical Limited (NASDAQ: MCTA). The SEC halted trading of MCTA on November 11, 2025, citing potential market manipulation through social media-based stock promotion schemes. The lawsuit alleges that company defendants made materially false statements and failed to disclose fraudulent stock promotion activities, insider share dumping, and artificial trading activity that inflated the stock price.Benzinga · Feb 12, 2026

Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlancy Prongay Wolke & Rotter LLP reminds investors of the February 17, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Charming Medical Limited (MCTA). The SEC halted trading of MCTA securities on November 11, 2025, citing potential market manipulation through social media-based stock promotion schemes. The lawsuit alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity that inflated the stock price.Benzinga · Feb 12, 2026

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmThe Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 after its shares spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors are encouraged to contact the firm before February 17, 2026.Benzinga · Feb 9, 2026

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Charming Medical Ltd. (NASDAQ: MCTA) alleging that company defendants failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and coordinated share dumping by insiders. The lawsuit covers investors who purchased securities between October 10, 2025 and November 12, 2025. Investors have until February 17, 2026 to request lead plaintiff status.GlobeNewswire Inc. · Feb 9, 2026

to start trading

MC

MCTACharming Medical Limited Class A Ordinary Shares

MCTA

Pay with—

Available Balance0.00

Your PositionYou don't own any MCTA yet.

Related Tickers

Earnings